Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies
- 1 November 2015
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 29 (6) , 405-415
Abstract
No abstract availableKeywords
Funding Information
- University of Queensland Diamantina Institute
This publication has 93 references indexed in Scilit:
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphomaNature Genetics, 2014
- Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingNature Genetics, 2012
- Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphomaJournal of Experimental Medicine, 2012
- The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentJournal of Experimental Medicine, 2012
- Analysis of the coding genome of diffuse large B-cell lymphomaNature Genetics, 2011
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Inactivating mutations of acetyltransferase genes in B-cell lymphomaNature, 2011
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin LymphomaJournal of Experimental Medicine, 2003
- The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaBlood, 2003
- Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase DomainMolecular and Cellular Biology, 2000